Physician

Adam M Forman, MD

According to 2025 Medicare claims, Adam Forman, MD (NPI: 1992094296) practices hematology/oncology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is HENRY FORD HEALTH ST. JOHN HOSPITAL (NPI: 1912965088; TIN: 381359063) and primary practice location at 48374-1262. Forman is affiliated with the St. John Providence ACO, LLC (ACO ID: A5417), participating under the MSSP model.

Forman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 450 traditional Medicare patients, billed 1,193 HCPCS/CPT codes, and received $99,684 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,489 prescription claims across 274 beneficiaries totaling $5,225,770 in drug costs, led by Pomalyst (Pomalidomide). DME data shows 36 claims. Open Payments data shows 42 records totaling $74,378. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $44,353 to $5,225,770. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	150	464	$37,955
2019	331	1,312	$101,043
2020	319	1,202	$89,824
2021	354	1,239	$103,493
2022	368	1,127	$86,521
2023	419	1,129	$93,059
2024	450	1,193	$99,684

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	78	462	$44,353
2016	52	121	$5,991
2017	29	77	$6,488
2018	45	125	$224,220
2019	120	546	$774,238
2020	154	799	$1,699,519
2021	175	876	$2,494,724
2022	190	1,019	$3,452,045
2023	232	1,291	$4,330,348
2024	274	1,489	$5,225,770

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	15	$2,256
2021	N/R	43	$3,783
2022	N/R	24	$1,086
2023	N/R	N/R	N/R
2024	N/R	36	$1,155

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	80	82	$136
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	55	76	$129
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	183	478	$84
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	67	114	$64
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	164	234	$52

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Pomalyst	Pomalidomide	34	952	$698,246
Revlimid	Lenalidomide	31	868	$674,894
Imbruvica	Ibrutinib	31	888	$500,145
Tagrisso	Osimertinib Mesylate	29	870	$480,567
Jakafi	Ruxolitinib Phosphate	24	720	$428,649

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	16	$779
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	20	$376

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	36	$42,233	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	6	$32,145	Ascension Providence Hospital
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam M. Forman, MD?

Tedicare shows public-source Medicare data for Adam M. Forman, MD (NPI 1992094296), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam M. Forman, MD have ACO affiliation data?

Adam M. Forman, MD is shown with ACO affiliation data for St. John Providence ACO, LLC (MSSP, ACO ID A5417).

What billing organization is linked to Adam M. Forman, MD?

Adam M. Forman, MD is linked to HENRY FORD HEALTH ST. JOHN HOSPITAL (billing NPI 1912965088) in the available physician profile data.

Does Adam M. Forman, MD have Open Payments data?

Adam M. Forman, MD has 42 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.